Specifically, we measured IFN-γ, GranzymeB, and CXCL9 [31, 32], markers known to be regulated by STAT1 and are associated with T cell anti-tumour activity, effector responses and chemotaxis of anti-tumour effector T cells. The gene discussed is STAT1; the disease is neoplasm.